ghk cu peptide injection dosage per day GHK-Cu Guide: Typical Protocols, & Topical KLOW Peptide Dosage & Protocol

Batch: GF-BPCTB5-B241 BPC-157 Assay: 7.36 mg BPC-157 Purity: 99.2 percent BPC-157 Identification by RT: 0.995 Molecular Ion Mass Identification (BPC-157): 1418 Da TB-500 Assay: 6.11 mg TB-500 Purity: greater than 99.8 percent TB-500 Identification by RT: 0.996 Molecular Ion Mass Identification (TB-500): 4963 Da Bacterial Endotoxins: below 0.001 EU/mg Total Aerobic Microbial Count: Not detected Total Yeast and Mold Count: Not detected Research Applications In controlled laboratory environments, BPC-157 / TB-500 may be utilised in experimental models designed to investigate peptide signalling systems and molecular interaction pathways

Pregnancy and lactation safety has not been systematically studied, and as with most cosmetic and research compounds lacking definitive pregnancy safety data, conservative practice typically suggests avoiding use during pregnancy unless clearly needed, though the natural occurrence of GHK-Cu in the body and minimal systemic absorption from topical use suggest risk is likely to be low

For detailed injection protocols including reconstitution, site rotation, and cycling strategies, see our complete GHK-CU injection dosage guide

Rocz Panstw Zakl Hig (2018) 69:1521